Advertisement
Screener

ENDRA LIFE SCIENCES INC. (NDRA) Clinical Trials

ENDRA LIFE SCIENCES INC. Clinical Trials

Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.

  • 2023-11-02: Study NCT04302051; Company role Collaborator; Phase Observational; Status Withdrawn.
Start dateStudyCompany rolePhaseStatusConditionsEnrollmentCompletion date
2023-11-02NCT04302051
Assessment of Fatty Liver With Thermo-acoustic Device
Collaborator
Lead: Medical College of Wisconsin
ObservationalWithdrawnNASH; NAFLD; Non-alcoholic Fatty Liver; Non-Alcoholic Fatty Liver Disease; Non-alcoholic Steatohepatitis; Fatty Liver; Fatty Liver Disease02026-07-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRIDEX CORP (IRIX)United States$0.011B
Nuwellis, Inc. (NUWE)United States$0.003B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B